Page results
-
A UCLH investment of £20 million will fund training for healthcare assistants and major new research facilities which will benefit patient care.
-
We are now administering new COVID-19 treatments for patients at highest risk in the community. The service can prescribe oral antivirals to be taken at home, and give intravenous antibody treatments at the hospital.
-
All semen analysis referrals should be made via the NHS e-Referral Service (e-RS). We will no longer be able to book semen analysis appointments through direct requests from patients or GP surgeries via email.
-
UCLH Charity’s magazine, Charity Matters is out now.
-
Men currently attending a hospital outpatient clinic for prostate hormone injections every 3 or 6 months will be advised that (unless not clinically appropriate) their next injection will be administered at a local GP practice, usually by the practice nurse.
-
People with obesity whose weight and health improve following drug treatment are likely to need the treatment long term, according to a UCLH and UCL study.
-
Achilles Therapeutics, a company built on research at UCLH, UCL Cancer Institute and the Francis Crick Institute has successfully raised $175.5 million through its initial public offering in the United States.
-
The High Court has today ruled in favour of a judicial review claim which means children and young people may not be able to consent to hormone-blocking treatment in cases of gender dysphoria.
-
I worked as a senior directorate accountant in finance in the NHS across a wide range of directorates, both corporate and clinical areas, working closely with these directorates on their financial plans, monitoring and forward planning.
-
The Freedom of Information Act 2000 (FOIA) came into force on 1 January 2005 giving members of the public certain rights to ask public authorities for information relating to the public authority.